SynteractHCR, a contract research organization (CRO) in Carlsbad, has hired Dr. Dieter Seitz-Tutter as vice president of global clinical operations.

This new position was established to accommodate the continued growth of the company as SynteractHCR extends its reach supporting the drug development programs of small to mid-sized biopharmaceutical companies.

Sietz-Tutter will join the senior management team, helping to ensure proper planning, conduct, patient safety, data quality, and all processes critical to clinical development. He will lead the company’s experienced clinical operations teams while fostering good communication between SynteractHCR, study sites and the sponsor.

Seitz-Tutter has more than 25 years of experience in clinical research — 20 of which he spent in the CRO (contract research organization) industry. Most recently, Seitz-Tutter was vice president of global clinical development at Chiltern where he was responsible for all clinical and country operations outside of North America. He also served as vice president for Europe at Medpace where he was responsible for clinical operations in 17 countries across Europe and Israel. Earlier in his career, he spent 13 years at Kendle where he served in different roles, including director of business development Europe, managing director Germany and vice president global clinical development Europe.

“Dieter’s extensive experience in the CRO industry and his knowledge of the global clinical market are very valuable to our clients,” said Wendel Barr, CEO of SynteractHCR.